Memorial Antalya Hospital
Antalya, Turkey
Hospital in Antalya
Zafer Mah. Yıldırım Beyazıt Cad. No - 91, Dokuma, 07025 Kepez/Antalya
About Memorial Antalya Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Loxo Oncology, Inc.
2
EMD Serono Research & Development Institute, Inc.
1
Incyte Corporation
1
Clinical Trials at Memorial Antalya Hospital
During the past decade, Memorial Antalya Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Avelumab in First-line NSCLC (JAVELIN Lung 100)
2015-10-29
2022-12-31
Active, not recruiting
1,214
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
2020-02-17
2027-07-01
Active, not recruiting
250
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
2020-09-27
2025-08-01
Recruiting
600
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
2020-11-27
2023-11-27
Active, not recruiting
303
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
2021-12-20
2032-11-30
Recruiting
170
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Antalya Hospital"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Memorial Antalya Hospital
According to Clinical.Site data, the most researched conditions in "Memorial Antalya Hospital" are
"Carcinoma, Non-Small-Cell Lung" (1 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials), "First Line Non-Small Cell Lung Cancer" (1 trials), "Metastatic Nonsquamous Non-Small Cell Lung Cancer" (1 trials) and "Metastatic Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Memorial Antalya Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Memorial Antalya Hospital
Most popular intervention types in "Memorial Antalya Hospital" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Cisplatin" (3 trials), "Paclitaxel" (3 trials), "Pemetrexed" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Memorial Antalya Hospital
The vast majority of trials in "Memorial Antalya Hospital" are
6 trials for "All" genders.
Clinical Trials Status at Memorial Antalya Hospital
Currently, there are NaN active trials in "Memorial Antalya Hospital".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Memorial Antalya Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Memorial Antalya Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".